WHEN CAN NON SIGNIFICANTLY DIFFERENT TREATMENTS BE CONSIDERED AS EQUIVALENT

被引：21

作者：

SPRIET, A

BEILER, D

机构：

来源：

关键词：

D O I：

10.1111/j.1365-2125.1979.tb04653.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：623 / 624

页数：2

共 17 条

[11]

OVERALL JE, 1967, ARCH GEN PSYCHIAT, V16, P152

SACKETT, DL ;

SPITZER, WO ;

GENT, M ;

ROBERTS, RS .

[13]

SPRIET A, 1978, EUR J DRUG METAB PH, V2, P129

[14]

STRICKLAND ID, 1977, CLIN NEPHROL, V7, P55

[15] SIGNIFICANT OR IMPORTANT [J].

WADE, OL ;

WATERHOUSE, JAH .

[16] SYMMETRICAL CONFIDENCE-INTERVALS FOR BIOEQUIVALENCE TRIALS [J].

WESTLAKE, WJ .

[17]

WULFF HR, 1973, LANCET, V1, P969